Metformin Vascular Adverse Lesions Type 1 Diabetes EASD 2017

Content for healthcare professionals only

View all Platforms Cardiology

Topics Content Type Videos Articles Journals Broadcasts Education Podcasts News Journals AER CFR ECR ICR3 JAPSC USC Faculty Events Upcoming Events Radcliffe Events All Events Resource Hubs Empagliflozin in the Treatment of Chronic Heart Failure Pulmonary Embolism Pulsed Field Ablation

Radcliffe Platforms

Radcliffe Group Cardiology Vascular CVRM Medical Education

Content for healthcare professionals only

Topics

Content Type

Journals

Faculty

Events

Resource Hubs

Video

EASD 2017: REMOVAL-Metformin Vascular Adverse Lesions in Type 1 Diabetes

Published: 26 Sep 2017

Views:
142
Likes:
0

Average (ratings)

No ratings

Your rating

This interview with Professor John Petrie from University of Glasgow, UK discusses Reducing with Metformin Vascular Adverse Lesions in Type 1 Diabetes (REMOVAL) at EASD 2017.

Filmed by Radcliffe Cardiology on-site at EASD 2017.